Biotics: An emerging food supplement for health improvement in the era of immune modulation.
Neelam A RevankarPradeep Singh NegiPublished in: Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition (2023)
The involvement of the commensal microbiota in immune function is a multifold process. Biotics, such as probiotics, prebiotics, synbiotics, and paraprobiotics, have been subjected to animal and human trials demonstrating the association between gut microbes and immunity biomarkers leading to improvement in overall health. In recent years, studies on human microbiome interaction have established the multifarious role of biotics in maintaining overall health. The consumption of biotics has been extensively reported to help in maintaining microbial diversity, enhancing gut-associated mucosal immune homeostasis, and providing protection against a wide range of lifestyle disorders. However, the establishment of biotics as an alternative therapy for a range of health conditions is yet to be ascertained. Despite the fact that scientific literature has demonstrated the correlation between biotics and immune modulation, most in vivo and in vitro reports are inconclusive on the dosage required. This review provides valuable insights into the immunomodulatory effects of biotics consumption based on evidence obtained from animal models and clinical trials. Furthermore, we highlight the optimal dosages of biotics that have been reported to deliver maximum health benefits. By identifying critical research gaps, we have suggested a roadmap for future investigations to advance our understanding of the intricate crosstalk between biotics and immune homeostasis.
Keyphrases
- public health
- healthcare
- mental health
- clinical trial
- health information
- endothelial cells
- systematic review
- health promotion
- physical activity
- multidrug resistant
- microbial community
- human health
- randomized controlled trial
- metabolic syndrome
- cardiovascular disease
- pluripotent stem cells
- open label
- study protocol
- double blind
- electronic health record